Skip to main content
  • ECLS Does Not Improve Survival Rates in Treating Infarct-Related Cardiogenic Shock, Study Finds

    The use of extracorporeal life support (ECLS) in patients with myocardial infarction (MI) and cardiogenic shock who underwent revascularization did not improve survival rates compared to those receiving medical therapy alone, a new study concludes.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details